Test Bank For Pharmacotherapeutics for Advanced Practice 3rd Edition by Virginia Poole Arcangelo, Andrew M. Peterson
Chapter 3. Impact of Drug Interactions and Adverse Events on Therapeutics
MULTIPLE CHOICE
1. Which of the following patients would be at higher risk of experiencing adverse drug reactions (ADRs):
A.
A 32-year-old male
B.
A 22-year-old female
C.
A 3-month-old female
D.
A 48-year-old male
ANS: C PTS: 1
2. Infants and young children are at higher risk of ADRs due to:
A.
Immature renal function in school-age children
B.
Lack of safety and efficacy studies in the pediatric population
C.
Children’s skin being thicker than adults, requiring higher dosages of topical medication
D.
Infant boys having a higher proportion of muscle mass, leading to a higher volume of distribution
ANS: B PTS: 1
3. The elderly are at high risk of ADRs due to:
A.
Having greater muscle mass than younger adults, leading to higher volume of distribution
B.
The extensive studies that have been conducted on drug safety in this age group
C.
The blood-brain barrier being less permeable, requiring higher doses to achieve therapeutic effect
D.
Age-related decrease in renal function
ANS: D PTS: 1
4. The type of adverse drug reaction that is the result of an unwanted but otherwise normal pharmacological action of a drug given in the usual therapeutic doses is
A.
Type A
B.
Type B
C.
Type C
D.
Type D
ANS: A PTS: 1
5. Digoxin may cause a Type A adverse drug reaction due to:
A.
Idiosyncratic effects
B.
Its narrow therapeutic index
C.
Being a teratogen
D.
Being a carcinogen
ANS: B PTS: 1
6. Changes in the individual pharmacokinetic parameters of adsorption, distribution, or elimination may result in high concentrations of the drug in the body, leading to which type of adverse drug reaction?
A.
Type A
B.
Type C
C.
Type D
D.
Type E
ANS: A PTS: 1
7. According to the World Health Organization Classification, Type B adverse reactions are:
A.
When a drug is a teratogen
B.
When a drug is carcinogenic
C.
A delayed ADR, such as renal failure
D.
An allergic or idiosyncratic response
ANS: D PTS: 1
8. Sarah developed a rash after using a topical medication. This is a Type __ allergic drug reaction.
A.
I
B.
II
C.
III
D.
IV
ANS: D PTS: 1
9. A patient may develop neutropenia from using topical Silvadene for burns. Neutropenia is a(n):
A.
Cytotoxic hypersensitivity reaction
B.
Immune complex hypersensitivity
C.
Immediate hypersensitivity reaction
D.
Delayed hypersensitivity reaction
ANS: A PTS: 1
10. Anaphylactic shock is a:
A.
Type I reaction, called immediate hypersensitivity reaction
B.
Type II reaction, called cytotoxic hypersensitivity reaction
C.
Type III allergic reaction, called immune complex hypersensitivity
D.
Type IV allergic reaction, called delayed hypersensitivity reaction
ANS: A PTS: 1
Reviews
There are no reviews yet.